Monday, April 13, 2026 | 07:31 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch
Sensex (    %)
                             
Nifty (    %)
                             
Nifty Midcap(    %)
                             
Nifty Smallcap(    %)
                             
Nifty Bank(    %)
                             
Nifty IT(    %)
                             
Home / Markets / Marksans Pharma Ltd / Announcements / BSE

Marksans Pharma Ltd

Announcement under Regulation 30 (LODR)-Press Release / Media Release

09:12 AM, 15th May 2025

Marksans Pharma Limiteds wholly owned subsidiary Relonchem Limited receives Marketing Authorisation for its product Gabapentin 50 mg/ml oral solution from UK MHRA

More Marksans Pharma Ltd Announcements

    View more